DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Sartore-Bianchi A, Trusolino L, Martino C. et al.
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES).
Lancet Oncol 2016;
17: 738-746
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.